Contact Info
- 2776 University Drive
- Coral Springs, FL 33065
- Website: http://www.nutrapharma.com
- Phone: (954) 509-0911
- Email: investor.relations@nutrapharma.com
Update Company Info
Business Description
Nutra Pharma Corporation operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases, including Adrenomyeloneuropathy (AMN), Multiple Sclerosis (MS), and Human Immunodeficiency Virus (HIV). Additionally, the Company markets several drug products for sale for the treatment of pain under the brands Cobroxin and Nyloxin.
Financial Reporting/Disclosure
| Reporting Status | U.S. Registered & Reporting: SEC Filer |
| Audited Financials | Audited |
| Latest Report | Not Available |
| Regulatory Agency | Not Available |
| CIK | 0001119643 |
| Fiscal Year End | 12/31 |
| OTC Market Tier | OTC Pink Limited |
Profile Data
| SIC - Industry Classification | 2833 - Medicinal and botanicals |
| Incorporated In: | CA, USA |
| Year of Inc. | 2000 |
| Employees | Not Available |
Company Officers
| Rik Deitsch | President, CEO, CFO |
Company Directors
| Not Available |
Company Notes
- Note=12-31-04 company is in the development stage
- Formerly=Cyber-vitamin.com until 11-01
Service Providers
Auditor/Accountant Legal Counsel
Not Available
Investor Relations Firm
Not Available
NPHC Security Details
Share Structure
| Market Value1 | $4,130,609 | a/o May 23, 2012 |
| Shares Outstanding | 315,313,673 | a/o Nov 09, 2011 |
| Float | Not Available | |
| Authorized Shares | Not Available | |
| Par Value | 0.001 |
Shareholders
| Shareholders of Record | 259 | a/o Apr 01, 2011 |
Short Selling Data
| Short Interest | 2,962 (-98.17%) Mar 30, 2012 |
| Significant Failures to Deliver | No |
Transfer Agent(s)
| Standard Registrar and Transfer Co., Inc. |
1Market Value calculated only for respective security




